The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets - Sargeant, P; Farndale, RW; Sage, SO (FEBS Lett, 1993)